Investigating the association between ALK receptor tyrosine kinase inhibitors and pulmonary arterial hypertension: a disproportionality analysis from the WHO pharmacovigilance database
Charles Khouri, Alex Hlavaty, Matthieu Roustit, Jean-Luc Cracowski, Marie-Camille Chaumais, Marc Humbert, David Montani
European Respiratory Journal 2021 58: 2101576; DOI: 10.1183/13993003.01576-2021